Most Americans reported that health insurers are not successfully deflecting high healthcare spending and many survey respondents sought more transparency and out-of-pocket healthcare spending support...
Major payer organizations are reacting to payer-related aspects of the State of the Union address, including making permanent the American Rescue Plan Act premium subsidies and lowering drug...
While the nation’s overall healthcare spending trend has been gradually increasing starting in 1970, the US experienced a particularly steep healthcare spending incline in 2020 of nearly 10...
The drug inflation rebate provision included in the Build Back Better Act could lead to a $111 billion reduction in employer-sponsored health plan premiums between 2022 and 2031, according to an Urban...
Prescription drug spending in the US drives healthcare spending primarily due to high US drug pricing, not necessarily because of the number of drugs that providers prescribe use, a Commonwealth Fund...
In 2021, prescription drug benefits took many forms as employers and payers played with tier structures and cost-sharing strategies to help manage prescription drug costs for employees, a Kaiser Family...
The Build Back Better Act includes measures that aim to reduce Medicare Part D drug spending and bolster the ability for both Medicare Part D plans and potentially private payers to control drug...
The Biden administration has issued an interim final rule that requires group and individual health insurance market plans to send data related to prescription drug spending of both patients and their...
For certain diseases, some payers implement step therapy protocols that are stricter than clinical and regulatory entities have recommended, researchers found in a Health Affairs study.
“Step...
Outcomes-based contracts continue to be popular for certain therapies as healthcare costs mount, an Avalere study found.
Avalere’s findings draw on survey responses from 51 insurers and pharmacy...
Health Insurance Innovations, a short-term insurance policy under Health Plan Intermediaries Holdings, LLC, will pay $625,000 to settle allegations that the payer engaged in deceptive and illegal...
Using a subscription-based payment model to cover medication costs could have varying impacts on access to medication depending on the state that implemented the model, according to a study published...
The Alliance of Community Health Plans (ACHP) is urging the federal government to take action and lower prescription drug prices with a set of recommended actions.
The costs of prescription drugs...
Purchaser Business Group on Health (PBGH) supported President Joe Biden’s plan to allow Medicare to negotiate drug prices.
“The truth is high drug costs are perpetuated by all parties...
For over a decade, an increasing number of Medicare beneficiaries have shouldered catastrophic Medicare Part D drug spending that exceeds the catastrophic threshold, according to a recent Kaiser Family...
The majority of the average healthcare premium dollar goes toward prescription drugs and outpatient and inpatient hospital costs, according to AHIP’s most recent research.
AHIP looked at 30...
Update 1/15/2021: This article has been edited to reflect that GoodRx included newly approved drugs in its calculations, which accounted for the change in the number of drugs that the...
Many Medicare beneficiaries are transitioning from another Medicare plan to Medicare Advantage, with the migration driven in part by the opportunity for prescription coverage under Medicare Advantage,...
High prescription drug spending has racked the American healthcare system’s cost trends for decades.
Prescription drug spending will be one of the major factors influencing the 2020 medical...
The Massachusetts State Senate has passed a bill that would introduce step therapy reform, restricting a practice that payers commonly use to decrease patient prescription drug...
